BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT07667322-completion@plaintrial.com
DTSTAMP:20261027T055537Z
DTSTART;VALUE=DATE:20280801
SUMMARY:A Study to Investigate the Safety\, Tolerability\, Pharmacokinetics
 \, Immunogenicity\, and Pharmacodynamics of a New Subcutaneous Formulation
  of Ocrelizumab in Participants With Multiple Sclerosis — estimated comp
 letion date
DESCRIPTION:Recruiting. Saved on your PlainTrial shortlist. Full trial reco
 rd: https://plaintrial.com/trial/NCT07667322
URL:https://plaintrial.com/trial/NCT07667322
END:VEVENT
END:VCALENDAR
